Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00500071
Status:
COMPLETED
Last Update Posted:
2022-03-10
First Post:
2007-07-10
Brief Title:
Dose-Optimization Study Evaluating the Efficacy Safety and Tolerability of Vyvanse Lisdexamfetamine Dimesylate in Children Aged 6-12 Diagnosed With ADHD
Sponsor:
Shire
Organization:
Takeda
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Attention Deficit Hyperactivity Disorder ADHD |
Keywords: